Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-107088
Filing Date
2024-12-10
Accepted
2024-12-09 20:16:08
Documents
91
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0223979-10q_onconetix.htm   iXBRL 10-Q 1461784
2 CERTIFICATION ea022397901ex31-1_onconetix.htm EX-31.1 10832
3 CERTIFICATION ea022397901ex31-2_onconetix.htm EX-31.2 10920
4 CERTIFICATION ea022397901ex32-1_onconetix.htm EX-32.1 4182
5 CERTIFICATION ea022397901ex32-2_onconetix.htm EX-32.2 4195
  Complete submission text file 0001213900-24-107088.txt   9055874

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE onco-20240930.xsd EX-101.SCH 87908
7 XBRL CALCULATION FILE onco-20240930_cal.xml EX-101.CAL 83800
8 XBRL DEFINITION FILE onco-20240930_def.xml EX-101.DEF 478579
9 XBRL LABEL FILE onco-20240930_lab.xml EX-101.LAB 851142
10 XBRL PRESENTATION FILE onco-20240930_pre.xml EX-101.PRE 491669
94 EXTRACTED XBRL INSTANCE DOCUMENT ea0223979-10q_onconetix_htm.xml XML 966592
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41294 | Film No.: 241536822
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)